Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for 908 Devices Inc. (MASS : NSDQ)
 
 • Company Description   
908 Devices Inc. is a purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis. It conducts research, designs and manufactures products of mass spectrometry, microfluidic separations, software automation and machine learning. 908 Devices Inc. is headquartered in Boston.

Number of Employees: 246

 
 • Price / Volume Information   
Yesterday's Closing Price: $7.13 Daily Weekly Monthly
20 Day Moving Average: 755,593 shares
Shares Outstanding: 35.86 (millions)
Market Capitalization: $255.69 (millions)
Beta: 0.38
52 Week High: $8.06
52 Week Low: $1.81
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 19.83% 14.64%
12 Week 87.14% 52.68%
Year To Date 224.09% 207.20%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
645 Summer Street
-
Boston,MA 02210
USA
ph: 857-254-1500
fax: -
ir@908devices.com http://www.908devices.com
 
 • General Corporate Information   
Officers
Kevin J. Knopp - Chief Executive Officer and Director
E. Kevin Hrusovsky - Chairman of the Board of Directors
Joseph H. Griffith IV - Chief Financial Officer
Keith L. Crandell - Director
Fenel M. Eloi - Director

Peer Information
908 Devices Inc. (ABMD)
908 Devices Inc. (DMDS)
908 Devices Inc. (CPWY.)
908 Devices Inc. (EQUR)
908 Devices Inc. (ECIA)
908 Devices Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 65443P102
SIC: 3829
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/05/25
Share - Related Items
Shares Outstanding: 35.86
Most Recent Split Date: (:1)
Beta: 0.38
Market Capitalization: $255.69 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.16 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.62 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/05/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 1.60
Price/Cash Flow: -
Price / Sales: 4.16
EPS Growth
vs. Year Ago Period: 33.33%
vs. Previous Quarter: 31.25%
Sales Growth
vs. Year Ago Period: 17.88%
vs. Previous Quarter: -37.42%
ROE
06/30/25 - -
03/31/25 - -27.10
12/31/24 - -29.41
ROA
06/30/25 - -
03/31/25 - -20.49
12/31/24 - -22.32
Current Ratio
06/30/25 - -
03/31/25 - 7.62
12/31/24 - 4.10
Quick Ratio
06/30/25 - -
03/31/25 - 6.97
12/31/24 - 3.45
Operating Margin
06/30/25 - -
03/31/25 - -61.93
12/31/24 - -68.91
Net Margin
06/30/25 - -
03/31/25 - -28.80
12/31/24 - -121.09
Pre-Tax Margin
06/30/25 - -
03/31/25 - -124.44
12/31/24 - -121.56
Book Value
06/30/25 - -
03/31/25 - 4.46
12/31/24 - 3.29
Inventory Turnover
06/30/25 - -
03/31/25 - 1.99
12/31/24 - 1.73
Debt-to-Equity
06/30/25 - -
03/31/25 - 0.00
12/31/24 - 0.00
Debt-to-Capital
06/30/25 - -
03/31/25 - 0.00
12/31/24 - 0.00
 

Powered by Zacks Investment Research ©